The influence of different heparin surface concentrations and antithrombin-binding capacity on inflammation and coagulation

Biomaterials

Volumn 26, Issue 14, 2005, Pages 1731-1739

  Johnell, M ^a   Larsson, R ^b   Siegbahn, A ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Departments of Oncology   (Sweden)

Author keywords

Biocompatibility; Biomaterial; Cell activation; Heparin

Indexed keywords

BIOCOMPATIBILITY; BLOOD; CELLS; COAGULATION; CONCENTRATION (PROCESS); MACROMOLECULES; POLYVINYL CHLORIDES; RADIATION EFFECTS; SURFACES; TUBING;

CELL ACTIVATION; CORLINE HEPARIN SURFACE (CHS); INFLAMMATION; VOLUNTEERS;

BIOMEDICAL ENGINEERING;

ANTITHROMBIN; HEPARIN; INTERLEUKIN 6;

ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE AGGREGATION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ANTITHROMBINS; BLOOD COAGULATION; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPARIN; HUMANS; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MATERIALS TESTING; PLATELET ACTIVATION; POLYVINYL CHLORIDE;

EID: 9644275224     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.05.029     Document Type: Article

References (28)

1. Hunt B.J., Parratt R.N., Segal H.C., Sheikh S., Kallis P., Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg. 65:1998;712-718
2. Ben Abraham R., Weinbroum A.A., Dekel B., Paret G. Chemokines and the inflammatory response following cardiopulmonary bypass - a new target for therapeutic intervention? - a review. Paediatr Anaesth. 13:2003;655-661
3. Morrissey J.H. Tissue factor. an enzyme cofactor and a true receptor Thromb Haemostasis. 86:2001;66-74
4. Celi A., Pellegrini G., Lorenzet R., De Blasi A., Ready N., Furie B.C., et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA. 91:1994;8767-8771
5. Kappelmayer J., Bernabei A., Edmunds L.H. Jr., Edgington T.S., Colman R.W. Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ Res. 72:1993;1075-1081
6. Amirkhosravi A., Alexander M., May K., Francis D.A., Warnes G., Biggerstaff J., et al. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemostasis. 75:1996;87-95
7. Lindmark E., Tenno T., Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol. 20:2000;2322-2328
8. Tang L., Eaton J.W. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med. 178:1993;2147-2156
9. Barbucci R., Magnani A. Conformation of human plasma proteins at polymer surfaces. the effectiveness of surface heparinization Biomaterials. 15:1994;955-962
10. Cazenave J.P., Mulvihill J.N. Methods to study blood-surface interactions. Missirlis Y.F., Lemm W. Modern aspects of protein adsorption on biomaterials. 1991;49-53 Kluwer Academic Publishers, Dordrecht
11. Arefieva T.L., Krasnikova T.L. Monocytic cell adhesion to intact and plasmin-modified fibrinogen. possible involvement of Mac-1 (CD11b/CD18) and ICAM-1 (CD54) J Cell Physiol. 188:2001;403-409
12. Fan S.T., Edgington T.S. Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest. 87:1991;50-57
13. Wendel H.P., Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardio-Thorac Surg. 16:1999;342-350
14. Larm O., Larsson R., Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med Devices Artif Organs. 11:1983;161-173
15. Johnell M., Elgue G., Larsson R., Larsson A., Thelin S., Siegbahn A. Coagulation, fibrinolysis and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface. J Thorac Cardiovasc Surg. 124:2002;321-332
16. Johnell M., Elgue G., Thelin S., Larsson R., Siegbahn A. Cell adhesion and tissue factor upregulation in oxygenators used during coronary artery bypass grafting are modified by the corline heparin surface. Scand Cardiovasc J. 36:2002;351-357
17. Kristensen E.M.E., Rensmo H., Larsson R., Siegbahn H. Characterization of heparin surfaces using photoelectron spectroscopy and quartz crystal microbalance. Biomaterials. 24:2003;4153-4159
18. Andersson J., Sanchez J., Ekdahl K.N., Elgue G., Nilsson B., Larsson R. Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated blood in vitro. J Biomed Mater Res. 67A:2003;458-466
19. Tenno T., Botling J., Oberg F., Jossan S., Nilsson K., Siegbahn A. The role of RAR and RXR activation in retinoid-induced tissue factor suppression. Leukemia. 14:2000;1105-1111
20. Malarstig A., Tenno T., Jossan S., Aberg M., Siegbahn A. A quantitative real-time PCR method for tissue factor mRNA. Thromb Res. 112:2003;175-183
21. Li N., Goodall A.H., Hjemdahl P. Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry. 35:1999;154-161
22. Kjalke M., Monroe D.M., Hoffman M., Oliver J.A., Ezban M., Roberts H.R. Active site-inactivated factors VIIa, Xa and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation. Thromb Haemostasis. 80:1998;578-584
23. Petersen L.C. Active site-inhibited seven. mechanism of action including signal transduction Semin Hematol. 38(Suppl 12):2001;39-42
24. Kahn M.L., Nakanishi-Matsui M., Shapiro M.J., Ishihara H., Coughlin S.R. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 103:1999;879-887
25. Gong J., Larsson R., Ekdahl K.N., Mollnes T.E., Nilsson U., Nilsson B. Tubing loops as a model for cardiopulmonary bypass circuits. both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model J Clin Immunol. 16:1996;222-229
26. Neumann F.J., Marx N., Gawaz M., Brand K., Ott I., Rokitta C., et al. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation. 95:1997;2387-2394
27. Data on file at Corline Systems AB Box 956, SE-751 09 Uppsala, Sweden.
28. Larsson R. Heparin-binding to improve biocompatibility. In: Marcel Dekker, editor. Encyclopedia of biomaterials and bioengineering. New York: Marcel-Dekker; 2004, (in press).